BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22068112)

  • 21. Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome.
    Estrada A; Boyce AM; Brillante BA; Guthrie LC; Gafni RI; Collins MT
    Eur J Endocrinol; 2016 Nov; 175(5):477-483. PubMed ID: 27562402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
    Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
    N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Precocious puberty].
    Nakagawa Y; Ohzeki T
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():217-23. PubMed ID: 16689312
    [No Abstract]   [Full Text] [Related]  

  • 24. Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.
    Nunez SB; Calis K; Cutler GB; Jones J; Feuillan PP
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5730-3. PubMed ID: 14671160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. McCune-Albright syndrome: clinical picture and natural history in children and adolescents.
    Völkl TM; Dörr HG
    J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():551-9. PubMed ID: 16789617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy and safety of letrozole in treatment of McCune-Albright syndrome girls with peripheral precocious puberty].
    Xu D; Lu W; Wang X; Wang J; Xie Y; Dong Z; Wang W
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):291-296. PubMed ID: 32762164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paediatric management of endocrine complications in McCune-Albright syndrome.
    Zacharin M
    J Pediatr Endocrinol Metab; 2005 Jan; 18(1):33-41. PubMed ID: 15679067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperthyroidism with fibrous dysplasia: an unusual presentation of McCune-Albright syndrome.
    Bhat MH; Bhadada S; Dutta P; Bhansali A; Mittal BR
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):331-3. PubMed ID: 17516298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary central precocious puberty in a girl with McCune-Albright syndrome responds to treatment with GnRH analogue.
    Schmidt H; Kiess W
    J Pediatr Endocrinol Metab; 1998; 11(1):77-81. PubMed ID: 9642633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. McCune-Albright syndrome, a rare form of precocious puberty: Diagnosis, treatment, and follow-up.
    Gryngarten M; Comar H; Arcari A; Boulgourdjian E; Escobar ME; Domené H
    Arch Argent Pediatr; 2021 Oct; 119(5):e420-e427. PubMed ID: 34569743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of endocrine hyperfunction and phosphate wasting on bone in McCune-Albright syndrome.
    Lala R; Matarazzo P; Andreo M; Defilippi C; de Sanctis C
    J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():913-20. PubMed ID: 12199350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photosensitive drug eruption induced by bicalutamide within the UVB action spectrum.
    Sasada K; Sakabe J; Tamura A; Kasuya A; Shimauchi T; Ito T; Hirakawa S; Tokura Y
    Eur J Dermatol; 2012; 22(3):402-3. PubMed ID: 22503957
    [No Abstract]   [Full Text] [Related]  

  • 33. McCune-Albright syndrome.
    Dumitrescu CE; Collins MT
    Orphanet J Rare Dis; 2008 May; 3():12. PubMed ID: 18489744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. McCune Albright Syndrome (MCAS): a case series.
    Rao S; Colaco MP; Desai MP
    Indian Pediatr; 2003 Jan; 40(1):29-35. PubMed ID: 12554915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen treatment of progressive precocious puberty in a patient with McCune-Albright syndrome.
    Eugster EA; Shankar R; Feezle LK; Pescovitz OH
    J Pediatr Endocrinol Metab; 1999; 12(5):681-6. PubMed ID: 10703542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tamoxifen improved final height prediction in a girl with McCune-Albright syndrome: patient report and literature review.
    Sawathiparnich P; Osuwanaratana P; Santiprabhob J; Likitmaskul S
    J Pediatr Endocrinol Metab; 2006 Jan; 19(1):81-6. PubMed ID: 16509532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome.
    Feuillan PP; Jones J; Oerter KE; Manasco PK; Cutler GB
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1370-3. PubMed ID: 1955519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of precocious puberty in McCune-Albright syndrome.
    Mieszczak J; Eugster EA
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4(0 4):419-22. PubMed ID: 17982389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of autonomous ovarian follicular cyst with long-term anastrozole therapy.
    Engiz O; Berberoglu M; Siklar Z; Bilir P; Ocal G
    Indian J Pediatr; 2009 Sep; 76(9):950-1. PubMed ID: 19904510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Girls and Boys with McCune-Albright Syndrome with Precocious Puberty - Update 2017.
    Neyman A; Eugster EA
    Pediatr Endocrinol Rev; 2017 Dec; 15(2):136-141. PubMed ID: 29292624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.